2	O
.	O
1	O
.	O

Biological	O
samples	B-Multi-tissue_structure

Placental	B-Tissue
tissues	I-Tissue
from	O
the	O
first	O
trimester	O
legally	O
induced	O
abortions	O
(	O
8	O
-	O
12	O
weeks	O
of	O
gestation	O
)	O
were	O
obtained	O
from	O
the	O
Department	O
of	O
Obstetrics	O
and	O
Gynecology	O
at	O
the	O
Broussais	O
,	O
Saint	O
Vincent	O
de	O
Paul	O
and	O
Cochin	O
Hospitals	O
.	O

Second	O
trimester	O
placental	B-Tissue
tissues	I-Tissue
were	O
collected	O
at	O
the	O
time	O
of	O
termination	O
of	O
pregnancy	O
at	O
15	O
and	O
25	O
weeks	O
of	O
gestation	O
(	O
in	O
weeks	O
of	O
amenorrhea	O
)	O
in	O
trisomy	O
21	O
-	O
affected	O
pregnancies	O
.	O

Fetal	B-Developing_anatomical_structure
Down	O
syndrome	O
was	O
diagnosed	O
by	O
karyotyping	O
of	O
amniotic	B-Cell
fluid	I-Cell
cells	I-Cell
.	O

The	O
indication	O
of	O
amniocentesis	O
was	O
the	O
maternal	O
age	O
.	O

Term	O
placentas	B-Organ
were	O
obtained	O
after	O
elective	O
cesarean	O
section	O
from	O
healthy	O
mothers	O
near	O
term	O
with	O
uncomplicated	O
pregnancies	O
.	O

With	O
written	O
informed	O
consent	O
of	O
the	O
pregnant	O
woman	O
,	O
the	O
following	O
samples	B-Multi-tissue_structure
were	O
collected	O
at	O
term	O
:	O
a	O
fragment	B-Multi-tissue_structure
of	O
the	O
placenta	B-Organ
,	O
umbilical	B-Organism_substance
cord	I-Organism_substance
fetal	I-Organism_substance
blood	I-Organism_substance
and	O
maternal	O
blood	B-Organism_substance
.	O

The	O
placenta	B-Multi-tissue_structure
biopsy	I-Multi-tissue_structure
sample	I-Multi-tissue_structure
was	O
collected	O
at	O
a	O
depth	O
of	O
1	O
cm	O
and	O
at	O
a	O
distance	O
of	O
8	O
cm	O
from	O
the	O
edge	O
of	O
the	O
placenta	B-Organ
,	O
with	O
the	O
maternal	O
side	O
facing	O
upward	O
.	O

The	O
use	O
of	O
these	O
biological	O
samples	B-Multi-tissue_structure
was	O
approved	O
by	O
local	O
ethical	O
committee	O
.	O

Villous	B-Cell
cytotrophoblastic	I-Cell
cells	I-Cell
were	O
isolated	O
by	O
sequential	O
enzymatic	O
digestion	O
of	O
chorionic	B-Multi-tissue_structure
villi	I-Multi-tissue_structure
from	O
the	O
first	O
trimester	O
,	O
second	O
trimester	O
and	O
term	O
placenta	B-Organ
and	O
purified	O
on	O
a	O
discontinuous	O
percoll	O
gradient	O
,	O
as	O
described	O
previously	O
.	O
47	O
-	O
49	O
These	O
cells	B-Cell
were	O
positively	O
stained	O
for	O
cytokeratin	O
7	O
at	O
95	O
%	O
,	O
indicating	O
the	O
cytotrophoblastic	O
origin	O
of	O
the	O
cells	B-Cell
.	O

Placental	B-Cell
fibroblasts	I-Cell
were	O
isolated	O
by	O
prolonged	O
enzymatic	O
digestion	O
from	O
first	O
trimester	O
chorionic	B-Multi-tissue_structure
villi	I-Multi-tissue_structure
as	O
in	O
Malassine	O
et	O
al	O
.	O
50	O
Fibroblastic	B-Cell
cells	I-Cell
(	O
1	O
.	O
25	O
x	O
105	O
cells	O
/	O
mL	O
)	O
were	O
plated	O
on	O
35	O
-	O
mm	O
plastic	O
dishes	O
(	O
TPP	O
,	O
Switzerland	O
)	O
and	O
cultured	O
for	O
48	O
h	O
,	O
and	O
the	O
culture	O
medium	O
was	O
changed	O
daily	O
.	O

These	O
cultured	O
fibroblasts	B-Cell
were	O
characterized	O
using	O
immunocytochemistry	O
.	O

It	O
was	O
found	O
that	O
98	O
%	O
of	O
the	O
cells	B-Cell
were	O
vimentin	O
positive	O
and	O
also	O
positive	O
for	O
a	O
monoclonal	O
antibody	O
against	O
specific	O
fibroblast	B-Cell
antigen	O
(	O
clone	O
ASO2	O
,	O
Dianova	O
,	O
Hamburg	O
,	O
Germany	O
)	O
.	O

Owing	O
to	O
the	O
limited	O
amount	O
of	O
cells	B-Cell
,	O
only	O
DNA	O
was	O
extracted	O
.	O

